Physician
Andrew J Will MD PA
Andrew J Will MD PA was paid $5.14M by Medicaid between Jan 2018 and Dec 2024, across 29 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 77% of everything it billed.
33Billing provider infoANDREW J WILL MD PA
EDINA, MN 55439
EDINA, MN 55439
33aNPI1215003066assigned 11/24/2006
33bProvider typePhysical Medicine & Rehabilitation Physician
28Total paid$5.14M
24GClaims101,112
24DCodes billed29
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Physical Medicine & Rehabilitation Physician providers in Minnesota
Rank by total paid#2 of 19
Median peer was paid$17K
This provider vs. median310×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 13,639 | $197K | |
| 2019 | 14,429 | $817K | |
| 2020 | 13,752 | $628K | |
| 2021 | 18,201 | $994K | |
| 2022 | 15,499 | $908K | |
| 2023 | 15,182 | $879K | |
| 2024incomplete | 10,410 | $714K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 77% | 82,261 | 70,559 | $3.97M |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 7.8% | 10,077 | 9,469 | $402K |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | 6.6% | 2,900 | 2,851 | $337K |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed | 4.1% | 1,934 | 1,765 | $212K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 1.8% | 1,184 | 1,135 | $94K |
| 97162 | <1% | 628 | 581 | $36K | |
| 64483 | <1% | 335 | 324 | $27K | |
| 90791 | Psychiatric diagnostic evaluationPsychiatric diagnostic evaluation | <1% | 127 | 117 | $14K |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed | <1% | 68 | 68 | $13K |
| 20611 | <1% | 205 | 172 | $10K | |
| 62321 | <1% | 126 | 120 | $7K | |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | <1% | 96 | 93 | $4K |
17 more codes
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 40 | $3K |
| 64493 | <1% | 57 | $3K | |
| 64635 | <1% | 12 | $1K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 12 | $1K |
| 64494 | <1% | 31 | $1K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 46 | $686.73 |
| 96160 | <1% | 459 | $481.04 | |
| 20553 | <1% | 14 | $474.40 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 199 | $474.34 |
| 97535 | Self-care/home management training, each 15 minutes | <1% | 26 | $458.18 |
| 99401 | <1% | 13 | $311.58 | |
| 95972 | <1% | 12 | $261.95 | |
| 80305 | <1% | 174 | $203.22 | |
| J7999 | Compounded drug, not otherwise classified | <1% | 12 | $96.39 |
| 62369 | <1% | 25 | $4.69 | |
| 76942 | <1% | 26 | $0.86 | |
| 99244 | Office or other outpatient consultation, moderate to high complexity | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialWILL, ANDREW (OWNER)
| Provider | Location | Paid |
|---|---|---|
| Andrew J Will MD PA | Maple Grove, MN | $234K |
| Andrew J Will MD PA | Burnsville, MN | $211K |
| Andrew J Will MD PA | Woodbury, MN | $130K |
| Twin Cities Surgery Center, PA | Edina, MN | $128K |
| Twin Cities Anesthesia, P.A. | Edina, MN | $19K |
| Andrew J Will MD PA | Maplewood, MN | $17K |
| Andrew J Will MD PA | Chaska, MN | $1K |
| Burnsville Surgery Center, P.A. | Burnsville, MN | $0.00 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.